Unlock regulatory insights with Watson. Learn More

Determine that AstraZeneca LP's Xylocaine (lidocaine) 10% Oral Spray (NDA 14-394) was voluntarily withdrawn or withheld from sale for reasons other than safety or effficacy - CLOSED

KeyWord(s) withdrawn, 10%, lidocaine, xylocaine, nda 14-394, spray, oral, book, orange, CDER, Closed
Short title Determine that AstraZeneca LP's Xylocaine (lidocaine) 10% Oral Spray (NDA 14-394) was voluntarily withdrawn or withheld from sale for reasons other than safety or effficacy
Docket Item Code P
Center CDER
VIEW ALL (2)Primary Documents